GLP-1 weight-loss drugs Mounjaro and Zepbound have been removed from the Food and Drug Administration's (FDA) shortage list. ...

The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...

In a consultation the UK's drugs watchdog has now proposed the NHS expands its use for weight loss for those who are severely obese under a phased rollout.

Jelly Roll's wife Bunnie XO said she got sick and "s--t my brains out" after "microdosing" the weight loss drug tirzepatide, which is often marketed as Mounjaro or Zepbound.

The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...

Brands like Kourtney Kardashian’s Lemme are claiming to provide the same benefits as GLP-1 medications like Ozempic, Wegovy, ...

Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 569.58% and ...

Newly released data shows that the U.S. may have reached peak obesity in 2020 — and the timing unsurprisingly coincides with ...

3 Reasons to Buy BioAge Labs Stock Hand Over Fist in October was originally published by The Motley Fool ...

John Paulson is among the most well-known billionaires, famous for his long-term investing returns via his hedge fund Paulson ...